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Cryptosporidiosis Surveillance — United States, 2003–2005
 Jonathan S. Yoder, MSW, MPH
Michael J. Beach, PhD
Division of Parasitic Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases, CDC
Abstract
Problem/Condition: Cryptosporidiosis, a gastrointestinal illness, is caused by protozoa of the genus Cryptosporidium.
Reporting Period: 2003–2005.
System Description: State and two metropolitan health departments voluntarily reported cases of cryptosporidiosis
through CDC’s National Notifiable Diseases Surveillance System.
Results: During 2003–2005, the total number of reported cases of cryptosporidiosis increased from 3,505 for 2003 to
3,911 for 2004 and to 8,269 for 2005. All reporting areas submitted reports, with more reports from northern states.
Compared with other age groups, a greater number of case reports were received for children aged 1–9 years and adults
aged 30–39 years. Peak onset of illness occurred annually during early summer through early fall.
Interpretation: Transmission of cryptosporidiosis occurs throughout the United States, with increased diagnosis or
reporting occurring in northern states. An increase in cases reported for 2005 was attributable primarily to the occur-
rence of a single large recreational water-associated outbreak. State incidence figures should be compared with caution
because individual state surveillance systems have varying capabilities to detect cases, and reporting might vary. The
seasonal peak in age-specific case reports coincides with the summer recreational water season and might reflect
increased use of communal swimming venues (e.g., lakes, rivers, swimming pools, and water parks) by young children.
Public Health Action: Cryptosporidiosis surveillance provides data to educate public health practitioners and health-
care providers about the epidemiologic characteristics and the disease burden of cryptosporidiosis in the United States.
These data are used to improve reporting of cases, plan prevention efforts, and establish research priorities.
adults, but it has not proven effective for immunocompromised
persons (4,5).
Cryptosporidium is a genus of protozoan parasites within
the phylum Apicomplexa, and its taxonomy continues to evolve.
Cryptosporidiosis is a zoonotic disease that causes clinical dis-
ease in both humans and animals; species names are based
primarily on the animal species serving as host (6). The
majority of human isolates were believed previously to belong
to a single species, Cryptosporidium parvum, but recent
advances in molecular methods have led to a more complete
understanding of the taxonomy of Cryptosporidium. Revised
taxonomic understanding has clarified that multiple species
infect humans, including C. hominis (known previously as
C. parvum genotype I), which primarily infects humans, and
C. parvum (known previously as C. parvum genotype II), which
infects both humans and ruminants. To a lesser extent,
human infections also have been documented with C. felis,
from cats; C. canis, from dogs; C. meleagridis, from birds;
C. suis, from pigs; C. muris, from rodents; and a C. cervine
genotype from various animals (6). Illnesses caused by infec-
tion from the different Cryptosporidium species are similar clini-
cally (7). Molecular studies also have demonstrated that
humans are susceptible to multiple subtypes of C. parvum
Introduction
Cryptosporidiosis is a gastrointestinal illness caused by pro-
tozoa of the genus Cryptosporidium (1). In otherwise well per-
sons, clinical illness is characterized by watery diarrhea, which
can be accompanied by abdominal cramps, loss of appetite,
low-grade fever, nausea, vomiting, and weight loss; however,
asymptomatic infection occurs frequently (2). Cryptosporidium
also can cause an opportunistic infection in human immuno-
deficiency virus (HIV)–infected patients, who might experi-
ence life-threatening infection with profuse, watery,
cholera-like diarrhea. However, incidence of this parasitic
infection among the HIV-infected population has decreased
since the introduction of highly active antiretroviral therapy
(HAART) for HIV infection (3). Nitazoxanide is the only
broad-spectrum antiparasitic drug that has been approved in
the United States for treatment of cryptosporidiosis.
Nitazoxanide can be prescribed for children aged >1 year and
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and C. hominis (6). Infected cattle serve as an important res-
ervoir of C. parvum and therefore are substantial contributors
to sporadic human cryptosporidiosis in certain areas (8,9).
A study conducted during 1996–2004 in the United King-
dom suggests that improvements in drinking water treatment
and source water protection might be responsible for decreasing
the number of cryptosporidiosis cases in humans caused by
C. parvum from ruminants (10,11). This benefit was influenced
by the culling of cattle herds during the British outbreak of
foot-and-mouth disease, which appeared to have had a substan-
tial impact on the transmission peak occurring during the spring
calving season (10–12).
Cryptosporidium infection is transmitted by the fecal-oral
route and results from the ingestion of Cryptosporidium
oocysts through the consumption of fecally contaminated food
or water or through direct person-to-person or animal-to-
person contact. The oocysts are infectious immediately upon
being excreted in feces. The infectious dose is low; feeding studies
have demonstrated that the ingestion of as few as 10–30 oocysts
can cause infection in healthy persons (13,14). Infected persons
have been reported to shed 108–109 oocysts in a single bowel
movement and to excrete oocysts for up to 50 days after cessation
of diarrhea (15,16).
Persons at increased risk for infection include 1) persons
who have contact with infected animals, 2) persons who have
ingested contaminated recreational (e.g., lake, river, pool, or
hot tub) or drinking water, 3) close contacts of infected per-
sons (e.g., those in the same family or household or in day
care settings), and 4) travelers to disease-endemic areas (1,8,9)
Although cryptosporidiosis cases occur sporadically, out-
breaks have been well documented since the first reported U.S.
drinking water-associated outbreak in 1984 (17) and the first
U.S. recreational water-associated outbreak in 1988 (18).
During 1988–2004, Cryptosporidium was identified as the
causal agent of 33% (63 of 189) of reported recreational water-
associated outbreaks and of 5.5% (12 of 219) of reported
drinking water-associated outbreaks of gastroenteritis (18–29).
Cryptosporidium has emerged as the most frequently recog-
nized cause of recreational water-associated outbreaks of gas-
troenteritis, particularly in treated (disinfected) venues. In
addition, foodborne outbreaks of cryptosporidiosis linked to
ill foodhandlers and unpasteurized apple cider have been
reported (30,31). Outbreaks resulting from person-to-person
transmission in day care centers and from animal-to-person
transmission in an animal nursery also have been reported
(32,33).
In 1994, the Council of State and Territorial Epidemiolo-
gists agreed to reporting of cryptosporidiosis as a nationally
notifiable disease; the first full year for reporting began in 1995.
Surveillance data for 1995–2002 have been published previ-
ously (34,35). This report summarizes national crypto-
sporidiosis surveillance data for 2003–2005.
Methods
A confirmed case is one that has a positive laboratory find-
ing. Confirmed cases of cryptosporidiosis in humans are
reported voluntarily to CDC. Confirmed cryptosporidiosis is
defined as the detection (in symptomatic or asymptomatic
persons) of Cryptosporidium
• oocysts in stool or intestinal fluid by microscopic exami-
nation with or without staining (e.g., modified acid-fast)
or by fluorescent antibody assays, either direct (DFA) or
indirect (IFA); or
• oocyst or sporozoite antigens in stool or intestinal fluid
by immunodiagnostic methods (e.g., enzyme immunoas-
say [EIA]); or
• parasite DNA in stool, in intestinal or other bodily fluids
(e.g., bile or sputum), or in tissue samples by polymerase
chain reaction techniques when available; or
• life-cycle stages (e.g., trophozoites or merozoites) in
tissue samples (36,37).
A probable case of cryptosporidiosis is a clinically compat-
ible case that is linked epidemiologically to a confirmed case.
Because the case definition used by CDC does not include
probable cases (36), certain states or areas report only con-
firmed cases of cryptosporidiosis. However, certain jurisdic-
tions also report probable cases. A discussion has been initiated
with partners regarding adding probable cases to the case defi-
nition. This surveillance summary includes both confirmed
and probable cases as reported by jurisdictions.
Testing for Cryptosporidium is not always included in routine
examination of stool for ova and parasites (1). Commercially
available immunoassay kits are available and might be more
sensitive and specific than routine microscopic examination.
DFA is an extremely sensitive and specific detection method
and is considered the “gold standard” by many laboratorians;
other immunodiagnostic kits that do not require microscopy
(e.g., EIA and rapid immunochromatographic cartridge assays)
also are available (38). Rapid immunoassays do not take the
place of routine ova and parasite examination but might be
useful in diagnosing Cryptosporidium infections. Only molecu-
lar testing (e.g., polymerase chain reaction) can be used to spe-
ciate Cryptosporidium; however, no species data are reported to
CDC.
State, District of Columbia (DC), and New York City (NYC)
health department jurisdictions voluntarily report cases of
cryptosporidiosis to CDC through the National Notifiable
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Diseases Surveillance System (NNDSS). Reports include the
patient’s place of residence (i.e., state and county), age, sex,
race, ethnicity (i.e., Hispanic or non-Hispanic) and date of
illness onset and indicate whether the case is linked to a known
outbreak. An outbreak-related case is a laboratory-confirmed
or probable case that is linked epidemiologically to at least
one laboratory-confirmed case. Before analysis, these surveil-
lance data were verified for accuracy by the reporting source
and were finalized as of February 16, 2007. Because this sur-
veillance summary includes probable cases of cryptosporidiosis
and the data were finalized by the reporting jurisdiction more
recently, the number of cases might differ slightly from the
number reported in CDC’s annual Summary of Notifiable
Diseases.
Analysis of national cryptosporidiosis surveillance data for
2003–2005 was conducted using SAS® v.9.1 (SAS Institute
Inc.; Cary, North Carolina) and the Food Safety Information
Link (FSI Link). FSI Link is an intranet-based tool available to
CDC staff that provides access to NNDSS data and is used to
monitor trends in, and investigate outbreaks of, reportable
foodborne and waterborne diseases. Population data from the
U.S. Census Bureau were used to calculate incidence rates.
Results
During 2003–2005, the total number of reported cases of
cryptosporidiosis increased 11.6%, from 3,505 for 2003 to
3,911 for 2004, and then increased 111.4% to 8,269 for 2005
(Table 1). Cases reported to be outbreak related ranged from
6.6% of all cases reported for 2003 to 41.7% of all cases
reported for 2005 (Table 1). All jurisdictions reported
cryptosporidiosis cases during the reporting period, and the
number of jurisdictions reporting more than four cases per
100,000 population increased from five in 2003 to seven in
2005 (Table 1).
For 2005, incidence of cryptosporidiosis per 100,000 popu-
lation ranged from 0.1 cases (in multiple states) to 18.2 cases
(in New York), with 12 jurisdictions reporting >2.5 cases per
100,000 population (Figure 1; Table 1). The higher incidence
of cryptosporidiosis in New York was influenced by a single
large outbreak among >3,000 persons. Increased reporting of
cases occurred in northern states.
These surveillance data display a bimodal age distribution,
with the greatest number of reported cases occurring among
children aged 1–9 years and among adults aged 30–39 years
(Figure 2). Increased reporting among younger children in
2005 was influenced by reporting of a single large outbreak in
New York that comprised many probable cases. When
reports for which a patient’s sex was unknown or missing are
excluded, the percentage of cases reported to have occurred
among males varied annually from 49.6% (4,069 of 8,197)
for 2005 to 55.9% (1,919 of 3,430) for 2003 (Table 2).
A tenfold increase in reported cryptosporidiosis cases by ill-
ness onset date occurred during June–October compared with
January–March (Figure 3). Age-specific analysis indicated that
the seasonality in onset of illness was exhibited across all age
groups, particularly among children aged 1–4 and 5–9 years
(Figure 4).
The majority of cases for which data on race were available
for 2003–2005 occurred among whites, followed by blacks,
Asians/Pacific Islanders, and American Indians/Alaska Natives
(Table 2). However, data on race were lacking for 28.3%–47.1%
of total annual case reports. Of patients for whom data on
ethnicity were reported, 10.5%–11.5% were reported to be
Hispanic (Table 2). However, data on ethnicity were lacking
for 41.0%–60.9% of total annual case reports for 2003–2005.
Discussion
National cryptosporidiosis surveillance data are used to
assess the epidemiologic characteristics and disease burden of
cryptosporidiosis in the United States. The total number of
cases reported annually increased during 2003–2005. Whether
this increase reflects changes in reporting patterns and
diagnostic testing practices or a real change in infection and
disease caused by Cryptosporidium is unclear but was clearly
influenced by outbreak-related case reporting. Outbreak-
related probable case reporting does not account for the
entire increase in reporting (Figure 5). This increase also fol-
lows the introduction of nitazoxanide, the first licensed treat-
ment for the disease (4). Nitazoxanide was licensed in 2002
for children aged 1–11 years and in 2004 for children aged
>11 years and adults. This drug introduction might have
affected clinical practice by increasing the likelihood of health-
care providers requesting Cryptosporidium testing, leading to
an increase in subsequent case reports. The geographic varia-
tion, age distribution, and late-summer through early-fall sea-
sonality were consistent with previous cryptosporidiosis
surveillance summaries (34,35).
Cryptosporidiosis is widespread geographically in the United
States. These data and data from previous national crypto-
sporidiosis surveillance summaries indicate that the
diagnosis or reporting of cryptosporidiosis might be higher in
northern states (34,35). However, differences in crypto-
sporidiosis surveillance systems and reporting among states
can affect the capability to detect and report cases, making
interpretation of this observation difficult.
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TABLE 1. Number* and percentage† of cryptosporidiosis case reports, by jurisdiction — United States,§ 2003–2005
2003 2004 2005
No. outbreak No. outbreak No. outbreak
Jurisdiction No. (%) Rate¶ cases** No. (%) Rate cases No. (%) Rate cases
Alabama 56 (1.6) 1.2 25 (0.7) 0.6 29 (0.4) 0.6
Alaska 1 (<0.1) 0.2 NR†† 3 (<0.1) 0.5
Arizona 6 (0.2) 0.1 17 (0.5) 0.3 11 (0.1) 0.2
Arkansas 22 (0.6) 0.8 16 (0.4) 0.6 8 (0.1) 0.3
California 287 (8.2) 0.8 574 (14.7) 1.6 336 214 (2.6) 0.6
Colorado 38 (1.1) 0.8 59 (1.6) 1.3 50 (0.6) 1.1 8
Connecticut 20 (0.6) 0.6 31 (0.9) 0.9 84 (1.0) 2.4
Delaware 5 (0.1) 0.6 1 (0.0) 0.1 6 (0.1) 0.7
District of Columbia 14 (0.4) 2.5 16 (0.4) 2.9 18 (0.2) 3.3
Florida 128 (3.7) 0.8 14 149 (4.1) 0.9 7 350 (4.2) 2.0 83
Georgia 122 (3.5) 1.4 177 (4.9) 2.0 152 (1.8) 1.7
Hawaii NR 2 (0.1) 0.2 1 (<0.1) 0.1
Idaho 27 (0.8) 2.0 28 (0.8) 2.0 15 (0.2) 1.0
Illinois 102 (2.9) 0.8 161 (4.4) 1.3 37 160 (1.9) 1.3 17
Indiana 126 (3.6) 2.0 79 (1.0) 1.3 94 (1.1) 1.5
Iowa 122 (3.5) 4.1 38 90 (2.5) 3.0 1 122 (1.5) 4.1 24
Kansas 174 (5.0) 6.4 96 31 (0.9) 1.1 40 (0.5) 1.5 7
Kentucky 27 (0.8) 0.7 47 (0.6) 1.1 2 149 (1.8) 3.6 102
Louisiana 5 (0.1) 0.1 7 (0.2) 0.2 83 (1.0) 1.8 25
Maine 20 (0.6) 1.5 22 (0.6) 1.7 30 (0.4) 2.3
Maryland 29 (0.8) 0.5 26 (0.7) 0.5 34 (0.4) 0.6
Massachusetts 78 (2.2) 1.2 58 (1.6) 0.9 152 (1.8) 2.4 3
Michigan 152 (4.3) 1.5 1 157 (4.3) 1.6 2 112 (1.4) 1.1 1
Minnesota 155 (4.4) 3.1 23 147 (4.0) 2.9 166 (2.0) 3.2 6
Mississippi 10 (0.3) 0.3 30 (0.8) 1.0 3 (<0.1) 0.1
Missouri 52 (1.5) 0.9 78 (2.1) 1.4 246 (3.0) 4.2
Montana 18 (0.5) 2.0 34 (0.9) 3.7 16 23 (0.3) 2.5
Nebraska 33 (0.9) 1.9 29 (0.8) 1.7 29 (0.4) 1.6
Nevada 8 (0.2) 0.4 2 (0.1) 0.1 13 (0.2) 0.5
New Hampshire 26 (0.7) 2.0 26 30 (0.8) 2.3 40 (0.5) 3.1
New Jersey 19 (0.5) 0.2 46 (1.3) 0.5 58 (0.7) 0.7
New Mexico 17 (0.5) 0.9 21 (0.6) 1.1 18 (0.2) 0.9
New York§§ 266 (7.6) 1.4 323 (8.9) 1.7 49 3,513 (42.5) 18.2 2,995¶¶
  New York City 126 (3.6) 1.5 (138) (3.8) 1.7 (148) (1.8) 1.8 1
North Carolina 57 (1.6) 0.7 2 76 (0.9) 0.9 6 92 (1.1) 1.1
North Dakota 15 (0.4) 2.4 12 (0.3) 1.9 5 (0.1) 0.8
Ohio 171 (4.9) 1.5 21 224 (6.2) 2.0 33 774 (9.4) 6.8 124
Oklahoma 24 (0.7) 0.7 22 (0.6) 0.6 46 (0.6) 1.3
Oregon 36 (1.0) 1.0 32 (0.9) 0.9 1 69 (0.8) 1.9 26
Pennsylvania 167 (4.8) 1.4 3 208 (5.7) 1.7 271 (3.3) 2.2 5
Rhode Island 17 (0.5) 1.6 4 (0.1) 0.4 19 (0.2) 1.8
South Carolina 16 (0.5) 0.4 24 (0.7) 0.6 24 (0.3) 0.6
South Dakota 49 (1.4) 6.4 44 (1.2) 5.7 2 31 (0.4) 4.0
Tennessee 43 (1.2) 0.7 49 (1.3) 0.8 49 (0.6) 0.8
Texas 80 (2.3) 0.4 105 (2.9) 0.5 115 (1.4) 0.5 1
Utah 20 (0.6) 0.8 6 (0.2) 0.2 11 (0.1) 0.4 1
Vermont 32 (0.9) 5.2 25 (0.7) 4.0 39 (0.5) 6.3
Virginia 56 (1.6) 0.8 66 (1.8) 0.9 77 (0.9) 1.0
Washington 62 (1.8) 1.0 63 (1.7) 1.0 100 (1.2) 1.6
West Virginia 4 (0.1) 0.2 6 (0.2) 0.3 21 (0.3) 1.2
Wisconsin 486 (13.9) 8.9 6 428 (11.8) 7.8 8 497 (6.0) 9.0
Wyoming 5 (0.1) 1.0 4 (0.1) 0.8 3 (<0.1) 0.6
Total 3,505 1.2 230 3,911 1.3 500 8,269 2.8 3,445
Sources: Population estimates are from the Population Division, U.S. Census Bureau. Annual estimates of the population for the United States: April 1, 2001 to July 1, 2005
(NST-EST 2005 01) available at http://www.census.gov/popest/states/tables/NST-EST2005-01.xls. Estimates of the New York City population: Annual estimates of the popu-
lation for incorporated places over 100,000, ranked by July 1, 2005 population: April 1, 2001 to July 1, 2005 (SUB-EST 2005-01) available at http://www.census.gov/popest/
cities/tables/SUB-EST2005-01.xls.
* Certain jurisdictions report probable cases despite this category being absent from the CDC case definition.
† Percentages might not total 100% because of rounding.
§ No reports were received from Puerto Rico, Freely Associated States, or U.S. territories.
¶ Per 100,000 population on the basis of U.S. Census Bureau population estimates.
** Number of cases linked epidemiologically to a laboratory-confirmed case.
†† No cases reported.
§§ New York state case reports include New York City.
¶¶ Includes cases from a large recreational water outbreak in New York state.
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FIGURE 1. Incidence* of cryptosporidiosis, by jurisdiction —
United States, 2005












Although cryptosporidiosis affects persons in all age groups,
the number of reported cases was highest among children aged
1–9 years and adults aged 30–39 years (Figure 2). These data
are consistent with reports of cryptosporidiosis incidence
being higher among younger children and of transmission to
their caregivers (e.g., child care staff, family members, and
other household contacts) (32,34,35,39,40). Because infor-
mation regarding immune system status is not collected as
part of NNDSS cryptosporidiosis reporting, the number of
immunosuppressed persons aged 30–39 years included in these
surveillance data is unknown. However, the introduction of
HAART therapy has decreased the amount of severe
cryptosporidiosis being diagnosed in the United States (3).
A tenfold increase in transmission of cryptosporidiosis
occurred during summer through early fall. This increase
coincided with increased outdoor activities (e.g., swimming
during the summer recreational water season) and might
reflect use of community swimming (essentially communal
bathing) venues by younger children (8,18–29). Crypto-
sporidium is the leading cause of reported recreational water-
associated outbreaks of gastroenteritis (19). Transmission
through recreational water is facilitated by the substantial
number of Cryptosporidium oocysts that can be shed by a single
person; the extended periods of time that oocysts can be shed
(15,16); the low infectious dose (13,14); the resistance of
Cryptosporidium oocysts to chlorine (41); and the prevalence
of improper pool maintenance (i.e., insufficient disinfection,
filtration, and recirculation of water), particularly of children’s
wading pools (18–29,42). This seasonal variation also has been
noted in state, Canadian provincial, and previous U.S.
national surveillance data for cryptosporidiosis and giardiasis
(34,35,39,40,43,45).
The marked seasonal variation, higher incidence among chil-
dren, and link to recreational water for cryptosporidiosis
reflects the substantial increase in cases reported for 2005 com-
pared with previous years (Figure 5). Of the 8,269 cases
reported, 3,513 were reported by New York state, including
2,995 outbreak-related cases. In July–August, 2005, New York
state experienced a cryptosporidiosis outbreak that sickened
>3,000 persons, including at least 425 persons with confirmed
cases, primarily children (46). The out-
break was associated with use of a rec-
reational water interactive fountain (i.e.,
a fountain or water/spray feature
intended for or accessible to recreational
use that typically does not have standing
water as part of the design). C. hominis
was detected in patient stools and the
holding tank of the interactive fountain.
Although the interactive fountain was
filtered and chlorinated, the treatment
was not sufficient to inactivate Crypto-
sporidium, which has high chlorine
resistance. This outbreak likely occurred
as a result of fecal contamination by an
infected patron and demonstrates why
Cryptosporidium has become the lead-
ing cause of outbreaks of gastrointesti-
nal illness associated with disinfected
recreational water venues (19).* Includes cases from a single large outbreak in New York state, primarily among children.†Case reports decreased with increased age. For each 5-year subgroup, the number of reported
cases was fewer than the number reported for persons aged 55–59 years.
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TABLE 2. Number and percentage* of cryptosporidiosis case reports,
by selected demographic characteristics — United States, 2003–2005
Demographic 2003 2004 2005
characteristics No. (%) No. (%) No. (%)
Sex
Male 1,919 (54.8) 1,945 (49.7) 4,069 (49.2)
Female 1,511 (43.1) 1,608 (41.1) 4,128 (49.9)
Unknown/Missing 75 (2.1) 358 (9.2) 72 (0.9)
Total 3,505 3,911 8,269
Race
AI/AN† 21 (0.6) 14 (0.3) 13 (0.2)
API§ 36 (1.0) 42 (1.1) 56 (0.7)
Black 269 (7.7) 339 (8.7) 378 (4.6)
White 2,140 (61.1) 2,146 (54.9) 3,587 (43.4)
Other 46 (1.3) 97 (2.5) 337 (4.1)
Unknown/Missing 993 (28.3) 1,273 (32.5) 3,898 (47.1)
Total 3,505 3,911 8,269
Ethnicity
Hispanic 235 (6.7) 247 (6.3) 339 (4.1)
Non-Hispanic 1,833 (52.3) 1,906 (48.7) 2,892 (35.0)
Unknown/Missing 1,437 (41.0) 1,758 (45.0) 5,038 (60.9)
Total 3,505 3,911 8,269
* Percentages might not total 100% because of rounding.
†American Indian/Alaska Native.
§Asian/Pacific Islander.
FIGURE 3. Number* of cryptosporidiosis case reports, by












FIGURE 4. Number of cryptosporidiosis case reports, by
selected age group* and month of illness onset — United
States, 2003–2005
* The 1–4- and 5–9-year age groups are presented because they have
the highest numbers of cryptosporidiosis case reports and have the
greatest seasonality. The 35–39-year age group was chosen to illustrate


















Outbreak reports reflecting the multiple routes of transmis-
sion for cryptosporidiosis also were reported during 2003–
2005. In 2003, unpasteurized apple cider made from
contaminated apples sickened 144 persons with
cryptosporidiosis (47). The cider was treated with ozone
despite the fact that no data exist regarding the efficacy of
ozone in treating food or juice products whose turbidity and
low temperature render ozonation less effective. Also in 2003,
a cryptosporidiosis outbreak that was associated with a middle-
and high-school educational farm program was reported (48).
Students participated in animal science classes and had con-
tact with calves; transmission was associated with
inadequate hygiene practices following animal con-
tact. The propensity for cryptosporidiosis outbreaks
to expand into communitywide outbreaks was un-
derscored by a Kansas outbreak in 2003; the inves-
tigation identified 96 laboratory-confirmed cases of
Cryptosporidium infection and >600 probable crypto-
sporidiosis cases (19). Multiple modes of transmission
were identified, including swimming pools used by
different swim teams and day camps and multiple
day care facilities in which water activities were preva-
lent (19). The need to educate swim staff and
develop work policies for employees who are ill with
diarrhea was demonstrated by a 2004 outbreak asso-
ciated with a recreational water park in California in
which 336 people were sickened (49). Many water
park employees were ill with a median onset date that
preceded that for ill members of the public. Park policy
required employees to be in the water regularly, and
no policy was in place for reassigning employees who
were ill with diarrhea (49).
Although previous surveillance reports have repeat-
edly demonstrated more reported cases among males (34,35,39),
a majority of reported cases in 2005 occurred among females.
Because data on race and ethnicity are incomplete, conclu-
sions cannot be made about differences in the epidemiology
of cryptosporidiosis among members of different racial and
ethnic populations.
The data reported likely underestimate the cryptosporidiosis
burden in the United States. Infection with enteric pathogens
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FIGURE 5. Incidence* of cryptosporidiosis, by year — United
States, 2003–2005 (n = 40,510)
* Per 100,000 population.















is highly underreported because 1) not all infected persons are
symptomatic, 2) those who are symptomatic do not always
seek medical care (50,51), 3) health-care providers infrequently
include laboratory diagnostics in their evaluation of nonbloody
diarrheal diseases (50), 4) a majority of laboratories do not
test for Cryptosporidium unless it is specifically requested (52),
and 5) case-reports are not always completed for positive labo-
ratory results or forwarded to public health officials (53). The
licensing of the first treatment for cryptosporidiosis (4) might
influence health-care providers to request Cryptosporidium test-
ing more often when ova and parasite exams are ordered.
Although the true burden of cryptosporidiosis in the United
States is unknown, an estimated 300,000 cases occur annu-
ally (53).
Its low infectious dose (13), protracted communicability
(15,16), and chlorine resistance (41) make Cryptosporidium
ideally suited for transmission through drinking and recre-
ational water, food, and both person-to-person and animal-
to-person contact. Although no formalized national prevention
plan exists for cryptosporidiosis, multiple efforts are focused
on reducing the transmission of the parasite through two major
routes of transmission. For drinking water, the Environmen-
tal Protection Agency (EPA) has implemented multiple regu-
lations designed to improve the safety of surface water (e.g.,
lakes and rivers) supplies, including multiple regulatory
changes following an outbreak in 1993 in Milwaukee, Wis-
consin, that sickened >400,000 persons using the city water
supply (19,20,54). Since 1993, no Cryptosporidium outbreaks
associated with use of community surface water supplies have
occurred (20,22–26). The signing of EPA’s Groundwater Rule
in 2006 marked an increased effort to decrease the risk associ-
ated with use of groundwater (well) supplies (20). This regu-
latory change is likely to decrease the continued occurrence of
Cryptosporidium outbreaks associated with groundwater use.
For recreational water, Cryptosporidium remains the leading
cause of diarrheal illness outbreaks, especially in chlorinated
venues (19). Efforts to reduce the transmission of this chlorine-
resistant pathogen in pools will require a concerted effort to
move beyond existing pool practices to include new technol-
ogy (ultraviolet light or ozone inactivation), operational
improvements (use of filtration enhancements that improve
Cryptosporidium removal), and public education to reduce the
continued swimming of people ill with diarrhea. In the United
States, no federal oversight of chlorinated swimming venues
occurs. All pool codes are reviewed and approved by state or
local public health officials. As a result, no uniform national
standards exist governing design, construction, operation, and
maintenance of swimming pools and other treated recreational
water venues. To provide guidance and improve pool code
uniformity across the nation, CDC has initiated an effort to
develop a National Model Aquatic Health Code and Risk
Reduction Plan (available at http://www.cdc.gov/healthy
swimming/model_code.htm). This effort will involve state,
local, and federal public health officials and the aquatics
industry in creating a voluntary model regulatory structure
for state and local health departments to use in developing
pool codes.
Continued vigilance regarding risk reduction efforts and
improving diagnosis and reporting of cryptosporidiosis are
needed to decrease the transmission of cryptosporidiosis in
the United States. Recommendations include prevention mea-
sures (Box 1) and measures to improve surveillance for
cryptosporidiosis and increase understanding of its epidemi-
ology and the associated disease burden (Box 2). General




Cryptosporidiosis data were reported to CDC by state, DC, and
NYC surveillance coordinators. Ruth Ann Jajosky, DMD, and
Roland Richard, MPH, National Center for Public Health
Informatics, CDC, facilitated access to the data and assisted with
the analysis. Technical assistance was provided by Michael Arrowood,
PhD, Michele Hlavsa, MPH, Stephanie Johnston, MS, John
Williamson, ScD, and Lihua Xiao, DVM, PhD, Division of Parasitic
Diseases, National Center for Zoonotic, Vector-Borne, and Enteric
Diseases, CDC.
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BOX 1. Recommendations to prevent and control cryptosporidiosis
Always practice good hand hygiene.
• Wash hands with soap and water for at least 20 seconds,
rubbing hands together vigorously and scrubbing all
surfaces
— after using the toilet,
— before handling food,
— after every diaper change (even if wearing gloves),
— after direct contact with preschool-aged children, and
— after any contact with animals or their feces.
Prevent contamination of recreational water (e.g.,
swimming pools, spas, interactive fountains, lakes,
rivers, and oceans).
• Do not swim while experiencing diarrheal illness (e.g.,
swimming in or entering the water at pools, spas, inter-
active fountains, lakes, rivers, or oceans) and for 2 weeks
after diarrhea or symptoms resolve if one has received a
diagnosis of cryptosporidiosis or during an outbreak of
cryptosporidiosis.
• Take children on frequent bathroom breaks and check
their diapers often.
• Change diapers in the bathroom, not at the poolside.
• Wash children thoroughly (especially their bottoms) with
soap and water after they use the toilet or their diapers
are changed and before they enter the water.
• Shower before entering the water.
Information about recreational water illnesses and how
to stop them from spreading is available from CDC at
http://www.cdc.gov/healthyswimming.
Prevent infection and illness caused by water that
might be contaminated.
• Do not swallow water in swimming pools, spas, or
interactive fountains.
• Do not swallow untreated water from lakes, rivers,
springs, ponds, streams, or shallow wells.
• Reduce persistent contamination of treated recreational
water venues by having pool operators install in-line
supplementary disinfection systems (e.g., ultraviolet light
or ozone) to inactive this chlorine-resistant parasite.
• Do not drink inadequately treated water during
communitywide outbreaks caused by contaminated
drinking water.
• Do not use or drink inadequately treated water when
traveling in countries where the water supply might be
unsafe.
• If the safety of drinking water is in doubt,
— disinfect it by heating the water to a rolling boil for
1 minute, or
— use a filter that has been tested and rated by
National Safety Foundation (NSF) Standard 53 or
NSF Standard 58 for cyst reduction; filtered water
will need additional treatment to kill or inactivate
bacteria and viruses.
Information about preventing infection and illness
caused by water that might be contaminated also is avail-
able from CDC at http://www.cdc.gov/healthyswimming.
Information about water filters and bottled water is avail-
able from CDC at http://www.cdc.gov/ncidod/dpd/
parasites/cryptosporidiosis/factsht_crypto_prevent_
water.htm.
Prevent infection and illness caused by eating food
that might be contaminated.
• Use properly treated water to wash all food that will be
eaten raw.
• Do not eat uncooked foods when traveling in areas where
cryptosporidiosis is common.
Prevent contact and contamination with feces during
sex.
• Use a barrier during oral-anal sex.
• Wash hands immediately after handling a condom used
during anal sex and after touching the anus or rectal area.
Additional recommendations for prevention and con-
trol of cryptosporidiosis for persons with compro-
mised immune systems.
• Minimize contact with the stool of all animals, particu-
larly young animals.
— Have others change litter boxes and clean cages.
— Wear disposable gloves when cleaning up after a
pet and always wash hands when finished.
• Wash hands after any contact with animals or their liv-
ing areas.
• Wash hands after gardening, even if wearing gloves.
• Wash, peel, and, if needed, cook, all raw vegetables.
• Boil or filter drinking water to ensure its safety, particu-
larly in an area experiencing an outbreak; filtered water
will need additional treatment to kill or inactivate bac-
teria and viruses.
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BOX 2. Recommended measures to improve surveillance for
cryptosporidiosis and increase understanding of its
epidemiology and associated disease burden
• Encourage health-care providers to consider and spe-
cifically request testing for Cryptosporidium in the evalu-
ation of gastrointestinal illness.
• Encourage laboratories that examine stool for ova and
parasites to test routinely for Cryptosporidium.
• Continue to educate health-care providers as well as
public and private laboratories to improve reporting of
cases of cryptosporidiosis to jurisdictional health departments.
• Encourage jurisdictional health departments to trans-
mit cryptosporidiosis data to CDC through the National
Electronic Disease Surveillance System (NEDSS), which
will replace the National Notifiable Diseases Surveillance
System (NNDSS).
• Publish and distribute cryptosporidiosis surveillance data
regularly for public health education purposes.
• Conduct further epidemiologic studies of the geographic
variability, incidence, and risk factors for cryptosporidiosis.
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Abstract
Problem/Condition: Giardiasis, a gastrointestinal illness, is caused by the protozoan parasite Giardia intestinalis.
Reporting Period: 2003–2005.
Description of System: State, commonwealth, territorial, and two metropolitan health departments voluntarily
reported cases of giardiasis through CDC’s National Notifiable Disease Surveillance System.
Results: During 2003–2005, the total number of reported cases of giardiasis remained relatively stable. Reporting
increased from 20,084 for 2003 to 20,962 for 2004 and then decreased to 20,075 for 2005. A total of 49 jurisdictions
reported giardiasis cases; the number of areas reporting >15 cases per 100,000 population increased from four areas in
2003 to seven in 2005. Compared with other age groups, a greater number of case reports were received for children
aged 1–9 years and for adults aged 30–39 years. Incidence of giardiasis was highest in northern states. Peak onset of
illness occurred annually during early summer through early fall.
Interpretation: Transmission of giardiasis occurs throughout the United States, with increased diagnosis or reporting
occurring in northern states. State incidence figures should be compared with caution because individual state surveil-
lance systems have varying capabilities to detect cases. The seasonal peak in age-specific case reports coincides with the
summer recreational water season and might reflect increased outdoor activity and exposures such as use of communal
swimming venues (e.g., lakes, rivers, swimming pools, and water parks) by young children.
Public Health Action: Giardiasis surveillance provides data to educate public health practitioners and health-care
providers about the epidemiologic characteristics and the disease burden of giardiasis in the United States. These data
are used to improve reporting of cases, plan prevention efforts, and establish research priorities.
transmission. The cysts are infectious immediately upon
being excreted in feces. The infectious dose is low; ingestion
of 10 cysts has been reported to cause infection (6). Infected
persons have been reported to shed <108–109 cysts in their
stool per day and to excrete cysts for months (6–8). Effective
treatment alternatives are available for patients with symp-
tomatic giardiasis, including metronidazole, nitazoxanide,
tinidazole, paromomycin, furazolidone, and quinacrine.
Persons at increased risk for infection include 1) travelers to
disease-endemic areas, 2) children in child care settings, 3)
close contacts of infected persons (e.g., those in the same fam-
ily or household or in the child care setting), 4) persons who
ingest contaminated drinking water, 5) persons who swallow
contaminated recreational water (e.g., water in lakes, rivers,
and pools), 6) persons taking part in outdoor activities (e.g.,
backpacking or camping) who consume unfiltered, untreated
water or who fail to practice good hygienic behaviors (e.g.,
hand washing), 7) persons who have contact with infected
animals, and 8) men who have sex with men (2,9–13),
although giardiasis does not appear to be opportunistic in per-
sons infected with human immunodeficiency virus. The rela-
tive contribution of person-to-person, animal-to-person,
Corresponding author: Jonathan S. Yoder, MSW, MPH, Division of Parasitic
Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases, CDC,
1600 Clifton Rd., N.E., MS F-22, Atlanta, GA 30333. Telephone: 770-488-
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Introduction
Giardia intestinalis (also known as G. lamblia and
G. duodenalis) is the most common intestinal parasite identi-
fied by public health laboratories in the United States (1). This
flagellated protozoan causes a generally self-limited clinical ill-
ness (i.e., giardiasis) typically characterized by diarrhea, abdomi-
nal cramps, bloating, weight loss, and malabsorption;
asymptomatic infection also occurs frequently (2–4). Case
reports indicate that giardiasis also might be associated with the
development of reactive arthritis (5). In addition, giardiasis
affects domestic and wild mammals (e.g., cats, dogs, cattle, deer,
and beavers) (2).
Giardia infection is transmitted by the fecal-oral route and
results from the ingestion of Giardia cysts through the con-
sumption of fecally contaminated food or water or through
person-to-person (or, to a lesser extent, animal-to-person)
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foodborne, and waterborne transmission to sporadic human
giardiasis in the United States is unknown.
Although giardiasis cases occur sporadically, outbreaks are
well documented. During 1995–2004, Giardia was identi-
fied as a causal agent of five (3.7%) of 136 reported cases of
recreational water-associated gastroenteritis outbreaks and of
14 (13%) of 108 reported cases of drinking water-associated
gastroenteritis outbreaks (14–20). In addition, foodborne
outbreaks of giardiasis linked to infected foodhandlers and to
uninfected foodhandlers who diapered infected children prior
to handling food have been reported (21). Outbreaks result-
ing from person-to-person transmission in child care centers
also have been reported (22). Communitywide outbreaks
might be waterborne initially but spread subsequently through
the community by person-to-person transmission (23). Few
direct animal-to-human outbreaks have been documented
although linkages have been identified between canine and
human transmission (24). In addition, animal contamination
of water (e.g., an infected dead beaver in a water system intake)
has been associated with drinking water outbreaks (25). How-
ever, the zoonotic transmission of giardiasis is not believed to
play a major role in human disease (26).
In 1992, the Council of State and Territorial Epidemiolo-
gists assigned an event code for giardiasis (code 11570) to
facilitate transmission of reported giardiasis data to CDC.
Surveillance data for 1992–2002 have been published previ-
ously (27,28). Reporting of giardiasis as a nationally notifi-
able disease began in 2002. This report summarizes national
giardiasis surveillance data for 2003–2005.
Methods
A confirmed case of giardiasis in humans is one that has a
positive laboratory finding. Confirmed and probable cases of
giardiasis are reported voluntarily to CDC. Confirmed giar-
diasis is defined as the detection (in symptomatic or asymp-
tomatic persons) of Giardia intestinalis
• cysts in stool specimens or trophozoites in stool speci-
mens, duodenal fluid, or small-bowel tissue by microscopic
examination using staining methods (e.g., trichrome) or
direct fluorescent antibody assays (DFA); or
• antigens in stool specimens by immunodiagnostic testing
(e.g., enzyme-linked immunosorbent assay) (29).
A probable case of giardiasis is a clinically compatible case
that is linked epidemiologically to a confirmed case (29).
Because Giardia cysts can be excreted intermittently, mul-
tiple stool collections (i.e., three stool specimens collected
every other day) increase test sensitivity (30). The use of con-
centration methods and trichrome staining might not be suf-
ficient to demonstrate Giardia because variability in the con-
centration of organisms in the stool can make this infection
difficult to diagnose. For that reason, fecal immunoassays with
greater sensitivities and specificities are available. DFA is
extremely sensitive and specific (31). Rapid immuno-
chromatographic cartridge assays also are available and are
useful for diagnosing Giardia infections, but they do not take
the place of routine ova and parasite examination.
Health departments in the 50 states, the District of Colum-
bia (DC), New York City (NYC), the Commonwealth of
Puerto Rico, and Guam voluntarily report laboratory-
confirmed and probable cases of giardiasis to CDC through
the Nationally Notifiable Disease Surveillance System
(NNDSS). Reports include the patient’s place of residence
(i.e., state and county), age, sex, race, ethnicity (i.e., Hispanic
or non-Hispanic), and date of illness onset and indicate
whether the case is linked epidemiologically to a known out-
break. An outbreak-related case is a case that is linked epide-
miologically to at least one laboratory-confirmed case. Before
analysis, data were verified for accuracy by the reporting juris-
diction and finalized as of February 16, 2007. For this reason,
the number of cases provided in this report might differ slightly
from the number published in CDC’s annual Summary of
Notifiable Diseases.
Analysis of the national giardiasis surveillance data for 2003–
2005 was conducted using SAS® v.9.1 (SAS Institute, Inc.;
Cary, North Carolina) and the Food Safety Information Link
(FSI Link). FSI Link is an intranet-based tool available to CDC
staff that provides access to NNDSS data and is used to moni-
tor trends in and investigate outbreaks of reportable foodborne
and waterborne diseases. Population data from the U.S. Cen-
sus Bureau were used to calculate incidence rates.
Results
During 2003–2005, the total number of reported cases of
giardiasis remained relatively stable. Case reports increased
4.4% from 20,084 for 2003 to 20,962 for 2004 and then
decreased 4.2% to 20,075 for 2005 (Table 1). Cases reported
to be outbreak related made up 1.1%–2.6% of the total num-
ber of cases reported annually for 2003–2005. During this
period, 49 jurisdictions reported giardiasis cases; the number
of jurisdictions reporting >15 cases per 100,000 population
increased from four in 2003 to seven in 2005.
For 2005, among jurisdictions reporting outbreaks, inci-
dence of giardiasis per 100,000 population ranged from 1.4
cases in Louisiana to 30 cases in Vermont. Two states
(Vermont and Minnesota) reported the greatest number of
cases per 100,000 population for each of the 3 years of the
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TABLE 1. Number and percentage* of giardiasis case reports, by jurisdiction — United States, 2003–2005
2003 2004 2005
No. outbreak No. outbreak No. outbreak
Jurisdiction No. (%) Rate† cases§ No. (%) Rate cases No. (%) Rate cases
Alabama 216 (1.1) 4.8 189 (0.9) 4.2 197 (1.0) 4.3
Alaska 89 (0.4) 13.7 101 (0.5) 15.4 110 (0.5) 16.6 1
Arizona 256 (1.3) 4.6 176 (0.8) 3.1 183 (0.9) 3.1
Arkansas 155 (0.8) 5.7 123 (0.6) 4.5 88 (0.4) 3.2
California 2,281 (11.4) 6.4 11 2,160 (10.3) 6.0 3 2,404 (12.0) 6.7 3
Colorado 467 (2.3) 10.3 515 (2.5) 11.2 1 534 (2.7) 11.4 5
Connecticut 369 (1.8) 10.6 1 506 (2.4) 14.5 395 (2.0) 11.3
Delaware 56 (0.3) 6.8 49 (0.2) 5.9 61 (0.3) 7.2
District of Columbia 61 (0.3) 10.9 76 (0.4) 13.7 56 (0.3) 10.2
Florida 1,132 (5.6) 6.7 139 1,126 (5.4) 6.5 81 987 (4.9) 5.5 58
Georgia 853 (4.2) 9.8 898 (4.3) 10.1 754 (3.8) 8.3
Hawaii 94 (0.5) 7.5 94 80 (0.4) 6.3 63 (0.3) 4.9 2
Idaho 206 (1.0) 15.1 212 (1.0) 15.2 155 (0.8) 10.8 2
Illinois 940 (4.7) 7.4 807 (3.8) 6.3 1 772 (3.8) 6.0 1
Indiana NR¶ NR NR
Iowa 277 (1.4) 9.4 17 305 (1.5) 10.3 280 (1.4) 9.4 1
Kansas 234 (1.2) 8.6 221 (1.1) 8.1 213 (1.1) 7.8
Kentucky NR NR NR
Louisiana 15 (0.1) 0.3 57 (0.3) 1.3 64 (0.3) 1.4
Maine 184 (0.9) 14.1 155 (0.7) 11.8 202 (1.0) 15.3
Maryland 118 (0.6) 2.1 160 (0.8) 2.9 210 (1.0) 3.7
Massachusetts 851 (4.2) 13.3 105 787 (3.8) 12.3 1 729 (3.6) 11.4 10
Michigan 781 (3.9) 7.7 718 (3.4) 7.1 783 (3.9) 7.7
Minnesota 851 (4.2) 16.8 27 1,398 (6.7) 27.4 1,241 (6.2) 24.2 7
Mississippi NR NR NR
Missouri 515 (2.6) 9.0 578 (2.8) 10.0 522 (2.6) 9.0
Montana 115 (0.6) 12.5 82 (0.4) 8.8 81 (0.4) 8.7
Nebraska 145 (0.7) 8.3 154 (0.7) 8.8 116 (0.6) 6.6
Nevada 139 (0.7) 6.2 131 (0.6) 5.6 113 (0.6) 4.7
New Hampshire 44 (0.2) 3.4 44 48 (0.2) 3.7 66 (0.3) 5.0
New Jersey 520 (2.6) 6.0 507 (2.4) 5.8 457 (2.3) 5.2
New Mexico 55 (0.3) 2.9 76 (0.4) 4.0 92 (0.5) 4.8
New York** 2,498 (12.4) 13.0 56 2,616 (12.5) 13.6 98 2,287 (11.4) 11.9 56
New York City 1,214 (6.0) 14.9 1,088 (5.2) 13.3 875 (4.4) 10.7
North Carolina NR NR NR
North Dakota 50 (0.2) 7.9 25 (0.1) 3.9 26 (0.1) 4.1
Ohio 901 (4.5) 7.9 13 807 (3.8) 7.0 60 817 (4.1) 7.1 18
Oklahoma 145 (0.7) 4.1 166 (0.8) 4.7 197 (1.0) 5.6
Oregon 411 (2.0) 11.5 1 442 (2.1) 12.3 2 415 (2.1) 11.4 2
Pennsylvania 1,024 (5.1) 8.3 1,024 (4.9) 8.3 885 (4.4) 7.1 8
Rhode Island 126 (0.6) 11.7 130 (0.6) 12.0 132 (0.7) 12.3
South Carolina 175 (0.9) 4.2 130 (0.6) 3.1 106 (0.5) 2.5
South Dakota 89 (0.4) 11.6 2 87 (0.4) 11.3 7 118 (0.6) 15.2 1
Tennessee 200 (1.0) 3.4 237 (1.1) 4.0 10 233 (1.2) 3.9
Texas NR NR NR
Utah 380 (1.9) 16.0 365 (1.7) 15.1 4 398 (2.0) 16.1 44
Vermont 122 (0.6) 19.7 168 (0.8) 27.0 11 187 (0.9) 30.0
Virginia 426 (2.1) 5.8 563 (2.7) 7.5 1 602 (3.0) 8.0
Washington 435 (2.2) 7.1 444 (2.1) 7.2 434 (2.2) 6.9
West Virginia 64 (0.3) 3.5 63 (0.3) 3.5 55 (0.3) 3.0
Wisconsin 630 (3.1) 11.5 4 966 (4.6) 17.6 1 938 (4.7) 16.9 5
Wyoming 23 (0.1) 4.6 27 (0.1) 5.3 31 (0.2) 6.1
Total 50 states 19,718 6.8 514 20,655 7.0 281 19,789 6.7 224
Guam 2 (<0.1) 1.2 5 (<0.1) 3.0 11 (0.1) 6.5
Puerto Rico 364 (1.8) 9.4 1 302 (1.4) 7.7 274 (1.4) 7.0
Total 20,084 6.8 515 20,962 7.0 281 20,075 6.7 224
Sources: Population estimates are from the Population Division, US Census Bureau. Annual estimates of the population for the United States and States and Puerto Rico: April 1,
2001 to July 1, 2005 (NST-EST 2005 01) available at http://www.census.gov/popest/states/tables/NST-EST2005-01.xls. Estimates of the New York City population: Annual
estimates of the population for incorporated places over 100,000, ranked by July 1, 2005 population: April 1, 2001 to July 1, 2005 (SUB-EST 2005-01) available at
http://www.census.gov/popest/cities/tables/SUB-EST2005-01.xls. Estimates of the population of Guam and Puerto Rico: International Data Base (IDB) data access – spreadsheet,
available at http://www.census.gov/ipc/www/idb.
* Percentages might not total 100% because of rounding.
† Per 100,000 population on the basis of U.S. Census Bureau population estimates.
§ Number of cases linked epidemiologically to a laboratory-confirmed case.
¶ No cases reported.
** New York state case reports include New York City.
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reporting period. Northern states reported more cases annu-
ally per 100,000 population than southern states (Figure 1;
Table 1).
These surveillance data display a bimodal age distribution,
with the greatest number of reported cases occurring among
children aged 1–4 and 5–9 years and adults aged 35–44 years
(Figure 2). When reports for which a patient’s sex was missing
or unknown are excluded, the percentage of cases reported to
have occurred among males varied annually from 55.0% (9,694
of 17,624) for 2003 to 55.9% (11,542 of 20,641) for 2004.
A twofold increase in reported giardiasis cases by onset of
illness occurred during June–October compared with January–
March (Figure 3). Age-specific analysis indicated a twofold
increase in onset of illness during June–October among all
age groups. The highest numbers of giardiasis cases were
reported among children aged 1–4 and 5–9 years and adults
aged 35–39 years (Figure 4).
The majority of cases for which data on race were available
for 2003–2005 occurred among whites, followed by blacks,
Asians/Pacific Islanders, and Native Americans/Alaska Natives
(Table 2). However, data on race were not included for 40.1%–
48.7% of total annual case reports. Although 13.7%–15.0%
of patients for whom data on ethnicity were reported were
identified as Hispanic, data on ethnicity were lacking for
47.8%–57.2% of total annual case reports.
Discussion
National giardiasis surveillance data are used to assess the
epidemiologic characteristics and disease burden of giardiasis
in the United States. During 2003–2005, the total number of
cases reported remained relatively stable, with a slight increase
during 2003–2004 and a slight decrease during 2004–2005.
However, following a gradual decline in case reports during
1996–2001 (27,28), the number of case reports appears to
have stabilized thereafter, coinciding with the disease becom-
ing nationally notifiable in 2002 (Figure 5). The reason for
this gradual decline is unknown.
Giardiasis is widespread geographically in the United States.
These data and data from previous national giardiasis surveil-
lance summaries (27,28) indicate that the diagnosis or trans-
mission of giardiasis might be higher
in northern states (Figure 1). However,
because differences in giardiasis surveil-
lance systems among states can affect
the capability to detect cases, whether
this finding is of true biologic signifi-
cance or is only the result of differences
in case detection or reporting is diffi-
cult to determine.
Although giardiasis affects persons in
all age groups, the number of reported
cases was highest among children aged
1–9 years and adults aged 35–44 years.
These data for younger age groups are
consistent with reports published pre-
viously of giardiasis incidence being
higher among younger children as well
as contributing to transmission to their
caregivers (e.g., day care staff, family
members, and other household contacts)
(2,27,28,32,33). A multicenter study
FIGURE 1. Incidence* of giardiasis, by state — United States,
2005
* Per 100,000 population.














FIGURE 2. Number* of giardiasis case reports, by age group and year — United
States, 2003–2005
* In 1,000s.
†Case reports decreased with increased age. For each 5-year subgroup, the number of reported
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identified Giardia as the cause of diarrhea in 15% of nondysenteric
children examined in outpatient clinics (34). Investigation of a
giardiasis outbreak in a day care facility determined that 47% of
ill children transmitted the infection to more than one house-
hold contact (35).
A marked seasonality in the onset of illness occurs in early
summer through early fall. A twofold increase in transmission
of giardiasis occurred during the summer, coinciding with
increased outdoor activities (e.g., swimming and camping).
This increase might reflect increased use of community swim-
ming (essentially communal bathing) venues by younger chil-
dren. In addition to animal contamination of surface water,
transmission through use of surface water (e.g., lakes
and rivers) and disinfected venues (e.g., swimming
pools and water parks) is facilitated by the substan-
tial number of Giardia cysts that can be shed by a
single person (7); the extended periods of time that
cysts can be shed (8); the low infectious dose (6);
the moderate resistance to chlorine of Giardia (36);
the prevalence of improper pool maintenance (i.e.,
insufficient disinfection, filtration, and
recirculation of water), particularly of children’s
wading pools (37); the prevalence of Giardia in
fecal material in pools (38); and documented trans-
mission of Giardia infection among diapered chil-
dren (22,34,35,39) who use swimming venues
regularly. This seasonal variation also has been noted
in state, Canadian provincial, and previous U.S. na-
tional surveillance data for giardiasis and as for
cryptosporidiosis (27,28,32,33).
The importance of water and food in the trans-
mission of Giardia is highlighted by recent giardia-
sis outbreaks. In 2003, a communitywide outbreak
of giardiasis in Massachusetts was traced to use of a
wading pool at a membership club (23). In addition to the 30
case-patients with primary exposures to the pool, an addi-
tional 105 cases were caused by secondary person-to-person
transmission. Also in 2003, a communitywide outbreak in
Iowa implicated a wading pool at a day care center that was
filled with water from the municipal water supply (14). From
the child care center, illness spread into the community via
secondary transmission, sickening an estimated 100 persons
with giardiasis, cryptosporidiosis, or both. In 2004, a drink-
ing water-associated outbreak in Ohio that sickened 1,450
FIGURE 3. Number* of giardiasis case reports, by month of















FIGURE 4. Number of giardiasis case reports, by selected age
group* and month of illness onset — United States, 2003–2005
* The three age groups (1–4, 5–9, and 35–39 years) with the highest
numbers of giardiasis case reports during 2003–2005 are presented;


















TABLE 2. Number and percentage* of giardiasis case reports, by
selected demographic characteristics — United States, 2003–2005
Demographic 2003 2004 2005
characteristics No. (%) No. (%) No. (%)
Sex
Male 9,694 (48.3) 11,542 (55.1) 10,909 (54.3)
Female 7,930 (39.5) 9,099 (43.4) 8,813 (43.9)
Unknown/Missing 2,460 (12.2) 321 (1.5) 353 (1.8)
Total 20,084 20,962 20,075
Race
AI/AN† 69 (0.3) 88 (0.4) 76 (0.4)
API§ 459 (2.3) 1,343 (6.4) 1,578 (7.9)
Black 957 (4.8) 1,640 (7.8) 1,398 (7.0)
White 8,430 (42.0) 8,342 (39.8) 8,321 (41.4)
Other 382 (1.9) 783 (3.7) 644 (3.2)
Unknown/Missing 9,787 (48.7) 8,766 (41.8) 8,058 (40.1)
Total 20,084 20,962 20,075
Ethnicity
Hispanic 1,173 (5.8) 1,600 (7.6) 1,524 (7.6)
Non-Hispanic 7,420 (37.0) 9,074 (43.3) 8,965 (44.7)
Unknown/Missing 11,491 (57.2) 10,288 (49.1) 9,586 (47.8)
Total 20,084 20,962 20,075
* Percentages might not total 100% because of rounding.
†American Indian/Alaska Native.
§Asian/Pacific Islander.
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persons was caused by multiple pathogens, including Giardia
(42). Contamination of noncommunity public and private
wells with sewage led to this communitywide outbreak.
Foodborne outbreaks associated with ice, vegetables, and
chicken salad also were reported in 2004 and 2005 (43).
Among patients for whom data on sex were reported, a
majority of cases occurred among males. This sex-related dif-
ference might be attributable in part to sexual contact among
men who have sex with men (11). However, the majority of
cases occurred in males in nearly every age group (except those
aged <1 year and >59 years), which suggests the influence of
other factors (Table 2). Because data on race and ethnicity
are incomplete, conclusions cannot be made regarding the dif-
ferences noted in the epidemiology of giardiasis among mem-
bers of different racial and ethnic populations.
The data reported likely underestimate the giardiasis bur-
den in the United States. Giardiasis is highly underreported
because 1) not all infected persons are symptomatic, 2) those
who are symptomatic do not always seek medical care (44,45),
3) health-care providers do not always include laboratory di-
agnostics in their evaluation of nonbloody diarrheal diseases
(44), and 4) case reports are not always completed for posi-
tive laboratory results or forwarded to public health officials
(46). Although the true burden of cryptosporidiosis in the
United States is unknown, an estimated 2 million cases occur
annually (46).
Its low infectious dose, protracted communicability, and
moderate chlorine resistance make Giardia ideally suited for
transmission through drinking and recreational water, food,
and person-to-person contact. Strategies to reduce the inci-
dence of giardiasis have focused on reducing waterborne
FIGURE 5. Incidence* of giardiasis, by year — United States,
1993–2005 (n = 294,435)
* Per 100,000 population.



















and person-to-person transmission. In response to parasitic
drinking water outbreaks related to treated surface water,
the Environmental Protection Agency (EPA) enacted the Sur-
face Water Treatment Rule (SWTR) and the Interim Enhanced
SWTR (15). These regulations have decreased the number of
giardiasis outbreaks associated with community drinking
water systems (15,17–20). In 2006, EPA finalized the Ground
Water Rule to address contamination of public ground water
(well) systems, which is likely to reduce the number of ground-
water-associated outbreaks of giardiasis. Person-to-person
transmission of Giardia is difficult to interrupt in a system-
atic fashion, particularly in day care settings (47). Adherence to
appropriate infection control (e.g., hand washing, diaper
changing, and separation of ill children) policies is recom-
mended for controlling giardiasis, and other enteric patho-
gens, in group settings such as daycares (48).
Prevention measures (Box 1) and measures to improve
surveillance for giardiasis and increase understanding of its
epidemiology and the associated disease burden (Box 2) have
been recommended. General information about giardiasis is
available from CDC at http://www.cdc.gov/ncidod/dpd/para-
sites/giardiasis/factsht_giardia.htm.
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BOX 2. Recommended measures to improve surveillance for
giardiasis and increase understanding of its epidemiology
and associated disease burden
• Encourage health-care providers to consider and spe-
cifically request testing for Giardia in the evaluation of
gastrointestinal illness (i.e., order testing of stool for ova
and parasites).
• Continue to educate health-care providers and public
and private laboratories to improve reporting of cases
of giardiasis to jurisdictional health departments.
• Encourage jurisdictional health departments to trans-
mit giardiasis data to CDC through the National Elec-
tronic Disease Surveillance System (NEDSS), which will
replace the National Notifiable Disease Surveillance
System (NNDSS).
• Publish and distribute giardiasis surveillance data regu-
larly for public health education purposes.
• Conduct further epidemiologic studies of the geographic
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